Ensem Therapeutics Alternatives & Competitors
12 companies similar to Ensem Therapeutics — Kinetic Ensemble™ Platform for Precision Medicine
Companies similar to Ensem Therapeutics
Bresso, Italy
TenSixty Biosciences
We're on a mission to create transformative drugs that will save lives and redefine oncolo...
Reverie Labs
Engineering next generation kinase inhibitors with computation.
Cambridge, United States
Rival Readout
Competing with Ensem Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Rapport Therapeutics
Precision medicines to match the complexity of the human brain.
United States
MOMA Therapeutics
Independently Excellent. Collectively Unstoppable.
Cambridge, United States
Frontier Medicines
Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transfor...
South San Francisco, Unit...
Afecta Pharmaceuticals
Creating Precision Medicines...More Efficiently
Irvine, United States
Matchpoint Therapeutics
Acing the future of covalent medicines
Exelixis
Exelixis works on discovering, developing, and commercializing therapies for the treatment...
Alameda, United States
Moderna
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Cambridge, United States
Nucleome Therapeutics
Nucleome Therapeutics is a biotechnology company using 3D genomics to discover precision m...
Oxford, United Kingdom
About Ensem Therapeutics
Ensem Therapeutics, founded in 2021 and headquartered in the United States, is making significant strides in the field of precision medicine with its proprietary Kinetic Ensemble™ Platform. This platform integrates cutting-edge computational techniques and AI, with advanced experimental methods to facilitate the discov...
Development of small molecule precision medicines, AI and ML integration for drug design, Discovery of cryptic binding pockets
Pharmaceutical companies, Biotechnology firms, Medical researchers, Oncology specialists
Drug Discovery, Precision Medicine, Oncology, Small Molecule Development, Kinetic Ensemble Platform, AI Deep Learning, Computational Drug Design, Structure-Based Drug Design, Non-Obvious Binding Pockets, Advanced Experimental Techniques, Difficult-to-Drug Targets, Genetic Disorders
B2B, Platform
Licensing, Service Fee, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Ensem Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Ensem Therapeutics on 28 Jan 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 20 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
